Physician, Investor, Venture Builder
TORONTO--(BUSINESS WIRE)--Neurable Inc., a leading developer of brain-computer interface (BCI) technology, and Healthspan Digital Inc., a Canadian HealthTech in precision health and longevity solutions, are thrilled to announce their collaboration...
Adrenology
Endocrinology
Genetics
Clinical Professor
Investor
Venture Builder
As the Co-Founder and Group CEO of NU, the multi-omics operating system for the longevity economy, I’m building the future of proactive, personalized healthcare—using cutting-edge technology and data-driven solutions to help people live longer, healthier lives.
With a background as a physician-investor specializing in endocrinology, hypertension, and genomic medicine, I bring a unique intersection of clinical expertise, venture investment, and technological innovation to the rapidly evolving longevity sector. Beyond NU, I am a Professor at the University of British Columbia and a Faculty Lecturer at the Geneva College of Longevity Science, where I focus on personalized medicine, multi-omics, and smart home health technology.
As Managing Partner of FHS Capital, I’ve backed and advised deep tech and health tech startups like Flyby, Eli Health, Science & Humans, Supernatural, Jung+, AI Nexus, Staque, ZOIME, Geneseq Marketplace, and Healthspan Digital. In short, companies pushing the boundaries of cost-effective, personalized healthcare.
My work is driven by the mission to build the infrastructure for longevity-focused healthcare, leveraging smart technologies and AI to empower individuals in optimizing their health. By integrating multi-omics, digital health, and precision medicine, NU is shaping the future of proactive, personalized longevity care at a global scale.
Education
2003-2009
Medical Degree, University of Jordan School of Medicine
2009-2012
Research Assistant, Vancouver General Hospital, University of British Columbia
2012-2015
Internal Medicine Residency, Yale School of Medicine
2015-2017
Fellowship in Endocrinology & Metabolism, National Institutes of Health
2017-2018
Fellowship in Clinical Biochemical Genetics, University of Toronto
2015-2019
Associate Investigator, Adrenal and Growth Hormone disorders, NICHD, NIH
2019-2021
Associate Program Director, NIH Endocrinology Fellowship Program
2019-2021
Director, Graduate Medical Education, NICHD, National Institutes of Health
2019-2021
Principal Investigator, Adrenal and Growth Hormone disorders, NICHD, NIH
2019-2022
Founding Editor-In-Chief, Endocrine and Metabolic Science (Elsevier)
2022
Assistant Clinical Professor, Department of Medicine, University of British Columbia
2024
Faculty, Geneva College of Longevity Science
ADVISORY, INVESTMENTS, VENTURES
Leaders on Purpose • YouTube
In this video, Dr. Fady Hannah-Shmouni delves into the fascinating world of longevity, uncovering essential topics that can significantly impact your health as you age.
Longevity Talk • Instagram
I’ve invested in many businesses, but I never invested in my health. Recently, I came across a clinic, “Lifespan Sports Medicine,” in Dubai, that specializes in longevity programs.
A book providing multidisciplinary guidance on transitioning young patients with genetic endocrine cancers to adult healthcare, covering diagnostics, treatment, and survivorship strategies.
A paper exploring the diagnostic approach to adrenal insufficiency through a case study of a 32-year-old woman, highlighting the role of cortisol and ACTH stimulation testing.
A set of guidelines providing comprehensive, evidence-based recommendations for preventing, diagnosing, and managing hypertension in adults and children, with new insights on resistant hypertension and hypertension in pregnancy.
A paper reassessing previous estimates, finding lower-than-reported rates in Ashkenazi Jews and Caucasians, highlighting its relevance in preconception and infertility counseling.
